Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Claritev Corporation

Claritev Corporation (CTEV) Stock Overview

Explore Claritev Corporation’s financial performance, market position, analyst ratings, and future outlook.

CTEV●NYSE
HealthcareMedical - Healthcare Information Services
$39.09
$1.14(2.83%)
U.S. Market opens in 8h 24m

Claritev Corporation (CTEV)

Meyka AI Score

Z

Key Financials

Market Cap664.7M
P/E Ratio-2.30
EPS (TTM)$-17.01
ROE1.40%
Fundamental Analysis

AI Price Forecasts

1 Month$26.07
3 Months$32.30
1 Year Target$28.10

CTEV Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Claritev Corporation (NYSE: CTEV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Claritev Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CTEV on the NYSE shows an RSI of 59.61, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $28.10 for the NYSE listing.

Key metrics behind Claritev Corporation's NYSE-traded stock include a P/E ratio of -2.30 and a market capitalization of 664.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CTEV on the NYSE.

Price Performance (NYSE: CTEV)

1-Day Change
-3.08%
5-Day Change
2.44%
1-Month Change
60.52%
3-Month Change
48.42%
6-Month Change
130.57%
Year-to-Date (YTD) Change
-8.80%
1-Year Change
-42.98%
3-Year Change
33.53%
5-Year Change
33.53%
All-Time (Max) Change
33.53%

Contact Information

https://www.claritev.com
(212) 780-2000
7900 Tysons One Place, McLean, VA, 22102

Company Facts

30,000 Employees
IPO DateApr 3, 2020
CountryUS
Actively Trading

Frequently Asked Questions